Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. 薬物名（臨床試験情報から抽出） DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY 指定難病告示番号
14-aminosalicylic acid extended release granules----1件: 96 💬
2Aceneuramic acid extended-release1件: Aceneuramic acid1件: Aceneuramic acid 💬 --1件: 30 💬
3Aceneuramic acid extended-release tablets1件: Aceneuramic acid1件: Aceneuramic acid 💬 --1件: 30 💬
4Advagraf prolonged-release hard capsules1件: Tacrolimus2件: Tacrolimus ,
Tacrolimus 💬 		5件: PPP3C,
PPP3C,
PPP3C,
PPP3R,
PPP3R 💬 		33件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬1件: 299 💬
5Alks 8700 delayed release (DR) capsule----1件: 13 💬
6Amantadine HCL extended release1件: Amantadine2件: Amantadine hydrochloride ,
Amantadine 💬 		5件: GRIN1,
GRIN2A,
GRIN2B,
GRIN2C,
GRIN2D 💬 		21件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬1件: 6 💬
7Amantadine HCL extended release capsule1件: Amantadine2件: Amantadine hydrochloride ,
Amantadine 💬 		5件: GRIN1,
GRIN2A,
GRIN2B,
GRIN2C,
GRIN2D 💬 		21件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬1件: 6 💬
8Amifampridine (base) with modified release1件: Amifampridine2件: Amifampridine ,
Amifampridine phosphate 💬 		4件: KCNA4,
KCNC3,
KCND2,
KCND3 💬 		4件: Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬1件: 11 💬
9Antioxidant plus pregabalin
(PREGABALIN EXTENDED RELEASE)		----1件: 298 💬
10Apriso 375 MG extended-release capsules----1件: 97 💬
11Arbaclofen extended release tablets1件: Arbaclofen1件: Arbaclofen 💬 2件: GABBR,
GABBR 💬 		8件: Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway 💬1件: 13 💬
12Asacol (mesalamine) delayed-release tablets1件: Mesalazine1件: Mesalamine 💬 --1件: 97 💬
13Asacol delayed release tablets1件: Mesalazine1件: Mesalamine 💬 --1件: 97 💬
14Asacol delayed-release tablets1件: Mesalazine1件: Mesalamine 💬 --1件: 97 💬
15AZD3241 extended release tablets 100 MG----1件: 6 💬
16AZD3241 extended release tablets 25 MG----1件: 6 💬
17Beraprost sodium 314D modified release tablets1件: Beraprost2件: Beraprost sodium ,
Beraprost 💬 		1件: PTGIR 💬 3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬1件: 86 💬
18Beraprost sodium modified release1件: Beraprost2件: Beraprost sodium ,
Beraprost 💬 		1件: PTGIR 💬 3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬1件: 86 💬
19Bydureon 2 MG powder and solvent FOR prolonged-release suspension1件: Exenatide1件: Exenatide 💬 1件: GLP1R 💬 4件: Hormone signaling, Insulin secretion, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 6 💬
20Carbidopa and levodopa controlled release tablets2件: Carbidopa,
Levodopa		2件: Levodopa ,
Carbidopa 💬 		6件: DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬 		17件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6 💬
21Carbidopa/levodopa, immediate release1件: Carbidopa1件: Carbidopa 💬 1件: DDC 💬 8件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬1件: 6 💬
22Continuous release dopamine agonists----1件: 6 💬
23Controlled-release levodopa / carbidopa----1件: 6 💬
24Cystagon (cysteamine bitartrate) immediate-release capsules1件: Cysteamine3件: Cysteamine ,
Cysteamine hydrochloride ,
Cysteamine bitartrate 💬 		--1件: 299 💬
25Cysteamine bitartrate delayed-release capsules1件: Cysteamine3件: Cysteamine ,
Cysteamine hydrochloride ,
Cysteamine bitartrate 💬 		--1件: 19 💬
26D-methylphenidate
(METHYLPHENIDATE HYDROCHLORIDE EXTENDED RELEASE)		----1件: 84 💬
27Dalfampridine ER, 10 MG oral tablet, extended release1件: Dalfampridine1件: Dalfampridine 💬 4件: KCNA4,
KCNC3,
KCND2,
KCND3 💬 		4件: Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬1件: 13 💬
28Darifenacin 7.5 MG extended release oral tablet1件: Darifenacin2件: Darifenacin hydrobromide ,
Darifenacin 💬 		1件: CHRM3 💬 12件: Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction 💬1件: 2 💬
29Deferiprone 600 MG delayed release tablet1件: Deferiprone1件: Deferiprone 💬 --1件: 6 💬
30Delayed and extended release mesalazine----1件: 97 💬
31Delayed release 6 mercaptopurine----1件: 96 💬
32Delayed release 6MP or calcitriol VS. purinethol----1件: 96 💬
33Diazoxide choline controlled-release tablet1件: Diazoxide2件: Diazoxide ,
Diazoxide choline 💬 		2件: ABCC8,
KCNJ11 💬 		4件: ABC transporters, GnRH secretion, Insulin secretion, Type II diabetes mellitus 💬1件: 193 💬
34Diclofenac
(DICLOFENAC SODIUM DELAYED RELEASE)		1件: Diclofenac5件: Diclofenac potassium ,
Diclofenac sodium (DICLOFENAC SODIUM DELAYED RELEASE),
Diclofenac ,
Diclofenac diethylamine ,
Diclofenac epolamine 💬 		2件: PTGS1,
PTGS2 💬 		23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Efferocytosis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬2件: 46, 271 💬
35Diclofenac + omeprazole
(DICLOFENAC SODIUM DELAYED RELEASE)		1件: Diclofenac5件: Diclofenac potassium ,
Diclofenac sodium (DICLOFENAC SODIUM DELAYED RELEASE),
Diclofenac ,
Diclofenac diethylamine ,
Diclofenac epolamine 💬 		2件: PTGS1,
PTGS2 💬 		23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Efferocytosis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬1件: 46 💬
36Diclofenac 50 milligrams
(DICLOFENAC SODIUM DELAYED RELEASE)		1件: Diclofenac5件: Diclofenac potassium ,
Diclofenac sodium (DICLOFENAC SODIUM DELAYED RELEASE),
Diclofenac ,
Diclofenac diethylamine ,
Diclofenac epolamine 💬 		2件: PTGS1,
PTGS2 💬 		23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Efferocytosis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬1件: 271 💬
37Diclofenac sodium
(DICLOFENAC SODIUM DELAYED RELEASE)		1件: Diclofenac5件: Diclofenac potassium ,
Diclofenac sodium (DICLOFENAC SODIUM DELAYED RELEASE),
Diclofenac ,
Diclofenac diethylamine ,
Diclofenac epolamine 💬 		2件: PTGS1,
PTGS2 💬 		23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Efferocytosis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬2件: 34, 46 💬
38Diclofenac sodium topical GEL
(DICLOFENAC SODIUM DELAYED RELEASE)		1件: Diclofenac5件: Diclofenac potassium ,
Diclofenac sodium (DICLOFENAC SODIUM DELAYED RELEASE),
Diclofenac ,
Diclofenac diethylamine ,
Diclofenac epolamine 💬 		2件: PTGS1,
PTGS2 💬 		23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Efferocytosis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬1件: 13 💬
39Diclofenac SR
(DICLOFENAC SODIUM DELAYED RELEASE)		1件: Diclofenac5件: Diclofenac potassium ,
Diclofenac sodium (DICLOFENAC SODIUM DELAYED RELEASE),
Diclofenac ,
Diclofenac diethylamine ,
Diclofenac epolamine 💬 		2件: PTGS1,
PTGS2 💬 		23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Efferocytosis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬1件: 271 💬
40Dihydroergotine mesylate sustained-release tablets----1件: 6 💬
41Diltiazem
(DILTIAZEM HYDROCHLORIDE EXTENDED RELEASE, DILTIAZEM HYDROCHLORIDE EXTENDED-RELEASE)		1件: Diltiazem3件: Diltiazem hydrochloride (DILTIAZEM HYDROCHLORIDE EXTENDED RELEASE, DILTIAZEM HYDROCHLORIDE EXTENDED-RELEASE),
Diltiazem malate ,
Diltiazem 💬 		4件: CACNA1C,
CACNA1D,
CACNA1F,
CACNA1S 💬 		37件: Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Arrhythmogenic right ventricular cardiomyopathy, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, Dilated cardiomyopathy, Dopaminergic synapse, GABAergic synapse, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hypertrophic cardiomyopathy, Insulin secretion, Long-term potentiation, MAPK signaling pathway, Oxytocin signaling pathway, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬3件: 51, 58, 88 💬
42Diltiazem hydrochloride
(DILTIAZEM HYDROCHLORIDE EXTENDED RELEASE, DILTIAZEM HYDROCHLORIDE EXTENDED-RELEASE)		1件: Diltiazem3件: Diltiazem hydrochloride (DILTIAZEM HYDROCHLORIDE EXTENDED RELEASE, DILTIAZEM HYDROCHLORIDE EXTENDED-RELEASE),
Diltiazem malate ,
Diltiazem 💬 		4件: CACNA1C,
CACNA1D,
CACNA1F,
CACNA1S 💬 		37件: Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Arrhythmogenic right ventricular cardiomyopathy, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, Dilated cardiomyopathy, Dopaminergic synapse, GABAergic synapse, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hypertrophic cardiomyopathy, Insulin secretion, Long-term potentiation, MAPK signaling pathway, Oxytocin signaling pathway, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 86 💬
43Efmody 10 MG modified release hard capsules1件: Hydrocortisone1件: Hydrocortisone 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 81 💬
44Efmody 5 MG modified release hard capsules1件: Hydrocortisone1件: Hydrocortisone 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 81 💬
45Extended release dipyridamole 200MG/aspirin 25MG----1件: 49 💬
46Extended release fampridine----1件: 13 💬
47Extended release melatonin----1件: 6 💬
48Extended-release oxycodone----1件: 13 💬
49Extended-release quetiapine fumarate----1件: 13 💬
50Fampyra 10 MG prolonged-release tablets1件: Dalfampridine1件: Dalfampridine 💬 4件: KCNA4,
KCNC3,
KCND2,
KCND3 💬 		4件: Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬1件: 13 💬
51Fampyra 10MG prolonged release tablets----1件: 13 💬
52Ferro duretter, prolonged release tablet----1件: 97 💬
53Firategrast immediate release tablet1件: Firategrast1件: Firategrast 💬 1件: ITGA4 💬 15件: Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Cytoskeleton in muscle cells, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection 💬1件: 13 💬
54Firategrast modified release tablet1件: Firategrast1件: Firategrast 💬 1件: ITGA4 💬 15件: Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Cytoskeleton in muscle cells, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection 💬1件: 13 💬
55Guanfacine extended release1件: Guanfacine2件: Guanfacine hydrochloride (GUANFACINE EXTENDED-RELEASE),
Guanfacine 💬 		1件: ADRA2A 💬 4件: Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬1件: 193 💬
56Hydrocortisone modified release capsules1件: Hydrocortisone1件: Hydrocortisone 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 81 💬
57IBD98-M delayed-release capsules----1件: 97 💬
58Immediate release carbidopa/levodopa1件: Carbidopa1件: Carbidopa 💬 1件: DDC 💬 8件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬1件: 6 💬
59Immediate release carbidopa/levodopa 10/100 MG2件: Carbidopa,
Levodopa		2件: Levodopa ,
Carbidopa 💬 		6件: DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬 		17件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6 💬
60Immediate release carbidopa/levodopa 25/100 MG2件: Carbidopa,
Levodopa		2件: Levodopa ,
Carbidopa 💬 		6件: DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬 		17件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6 💬
61Immediate release melatonin----1件: 6 💬
62KVD824 300 MG modified release tablets----1件: 65 💬
63KVD824 immediate-release capsule----1件: 65 💬
64KVD824 prototype 1 modified-release tablet----1件: 65 💬
65KVD824 prototype 2 modified-release tablet----1件: 65 💬
66KVD824 prototype 3 modified-release tablet----1件: 65 💬
67L-citrulline and metformin & L-citrulline
(METFORMIN HYDROCHLORIDE EXTENDED RELEASE, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE 500MG)		1件: Metformin2件: Metformin hydrochloride (METFORMIN HYDROCHLORIDE EXTENDED RELEASE, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE 500MG),
Metformin 💬 		2件: PRKAA,
PRKAA 💬 		20件: AMPK signaling pathway, Adipocytokine signaling pathway, Alcoholic liver disease, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway 💬1件: 113 💬
68Lamotrigine
(LAMOTRIGINE EXTENDED RELEASE)		1件: Lamotrigine1件: Lamotrigine (LAMOTRIGINE EXTENDED RELEASE) 💬 5件: SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN9A 💬 		3件: Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 💬5件: 13, 34, 113, 114, 144 💬
69Lamotrigine - generic product
(LAMOTRIGINE EXTENDED RELEASE)		1件: Lamotrigine1件: Lamotrigine (LAMOTRIGINE EXTENDED RELEASE) 💬 5件: SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN9A 💬 		3件: Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 💬1件: 38 💬
70Lamotrigine 25MG oral tablet, extended release1件: Lamotrigine1件: Lamotrigine (LAMOTRIGINE EXTENDED RELEASE) 💬 5件: SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN9A 💬 		3件: Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 💬1件: 114 💬
71Lamotrigine dispers
(LAMOTRIGINE EXTENDED RELEASE)		1件: Lamotrigine1件: Lamotrigine (LAMOTRIGINE EXTENDED RELEASE) 💬 5件: SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN9A 💬 		3件: Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 💬1件: 34 💬
72Lamotrigine extended release tablets1件: Lamotrigine1件: Lamotrigine (LAMOTRIGINE EXTENDED RELEASE) 💬 5件: SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN9A 💬 		3件: Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 💬1件: 13 💬
73Levodopa carbidopa (LC) oral encapsulated immediate release (IR) tablets2件: Carbidopa,
Levodopa		2件: Levodopa ,
Carbidopa 💬 		6件: DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬 		17件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6 💬
74Levodopa-carbidopa (LC) oral encapsulated immediate release (IR) tablets2件: Carbidopa,
Levodopa		2件: Levodopa ,
Carbidopa 💬 		6件: DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬 		17件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6 💬
75Levodopa-carbidopa immediate release1件: Levodopa1件: Levodopa 💬 5件: DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬 		13件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
76Levodopa-carbidopa immediate release (LC-IR) tablets1件: Levodopa1件: Levodopa 💬 5件: DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬 		13件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
77Levodopa-carbidopa multilayer extended release tablet2件: Carbidopa,
Levodopa		2件: Levodopa ,
Carbidopa 💬 		6件: DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬 		17件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6 💬
78LPM3770164 sustained release tablet----1件: 8 💬
79LPM3770164 sustained release tablet simulant----1件: 8 💬
80Mesalamine delayed release tablets 400MG1件: Mesalazine1件: Mesalamine 💬 --1件: 97 💬
81Mesalazine SLOW-release granules1件: Mesalazine1件: Mesalamine 💬 --1件: 97 💬
82Mesalazine sustained-release tablets1件: Mesalazine1件: Mesalamine 💬 --1件: 96 💬
83Metformin
(METFORMIN HYDROCHLORIDE EXTENDED RELEASE, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE 500MG)		1件: Metformin2件: Metformin hydrochloride (METFORMIN HYDROCHLORIDE EXTENDED RELEASE, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE 500MG),
Metformin 💬 		2件: PRKAA,
PRKAA 💬 		20件: AMPK signaling pathway, Adipocytokine signaling pathway, Alcoholic liver disease, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway 💬23件: 2, 6, 8, 13, 46, 49, 60, 65, 66, 67, 75, 77, 84, 86, 97, 113, 127, 206, 218, 225, 265, 285, 298 💬
84Metformin + standard OF care
(METFORMIN HYDROCHLORIDE EXTENDED RELEASE, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE 500MG)		1件: Metformin2件: Metformin hydrochloride (METFORMIN HYDROCHLORIDE EXTENDED RELEASE, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE 500MG),
Metformin 💬 		2件: PRKAA,
PRKAA 💬 		20件: AMPK signaling pathway, Adipocytokine signaling pathway, Alcoholic liver disease, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway 💬1件: 222 💬
85Metformin 1000 MG oral tablet
(METFORMIN HYDROCHLORIDE EXTENDED RELEASE, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE 500MG)		1件: Metformin2件: Metformin hydrochloride (METFORMIN HYDROCHLORIDE EXTENDED RELEASE, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE 500MG),
Metformin 💬 		2件: PRKAA,
PRKAA 💬 		20件: AMPK signaling pathway, Adipocytokine signaling pathway, Alcoholic liver disease, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway 💬1件: 13 💬
86Metformin 500 MG oral tablet, UP TO 4 tablets A DAY
(METFORMIN HYDROCHLORIDE EXTENDED RELEASE, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE 500MG)		1件: Metformin2件: Metformin hydrochloride (METFORMIN HYDROCHLORIDE EXTENDED RELEASE, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE 500MG),
Metformin 💬 		2件: PRKAA,
PRKAA 💬 		20件: AMPK signaling pathway, Adipocytokine signaling pathway, Alcoholic liver disease, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway 💬1件: 13 💬
87Metformin 500 MG TID oral tablet
(METFORMIN HYDROCHLORIDE EXTENDED RELEASE, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE 500MG)		1件: Metformin2件: Metformin hydrochloride (METFORMIN HYDROCHLORIDE EXTENDED RELEASE, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE 500MG),
Metformin 💬 		2件: PRKAA,
PRKAA 💬 		20件: AMPK signaling pathway, Adipocytokine signaling pathway, Alcoholic liver disease, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway 💬1件: 97 💬
88Metformin 500MG
(METFORMIN HYDROCHLORIDE EXTENDED RELEASE, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE 500MG)		1件: Metformin2件: Metformin hydrochloride (METFORMIN HYDROCHLORIDE EXTENDED RELEASE, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE 500MG),
Metformin 💬 		2件: PRKAA,
PRKAA 💬 		20件: AMPK signaling pathway, Adipocytokine signaling pathway, Alcoholic liver disease, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway 💬1件: 113 💬
89Metformin and clemastine IN combination
(METFORMIN HYDROCHLORIDE EXTENDED RELEASE, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE 500MG)		1件: Metformin2件: Metformin hydrochloride (METFORMIN HYDROCHLORIDE EXTENDED RELEASE, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE 500MG),
Metformin 💬 		2件: PRKAA,
PRKAA 💬 		20件: AMPK signaling pathway, Adipocytokine signaling pathway, Alcoholic liver disease, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway 💬1件: 13 💬
90Metformin and metformin & L-citrulline
(METFORMIN HYDROCHLORIDE EXTENDED RELEASE, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE 500MG)		1件: Metformin2件: Metformin hydrochloride (METFORMIN HYDROCHLORIDE EXTENDED RELEASE, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE 500MG),
Metformin 💬 		2件: PRKAA,
PRKAA 💬 		20件: AMPK signaling pathway, Adipocytokine signaling pathway, Alcoholic liver disease, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway 💬1件: 113 💬
91Metformin HCL
(METFORMIN HYDROCHLORIDE EXTENDED RELEASE, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE 500MG)		1件: Metformin2件: Metformin hydrochloride (METFORMIN HYDROCHLORIDE EXTENDED RELEASE, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE 500MG),
Metformin 💬 		2件: PRKAA,
PRKAA 💬 		20件: AMPK signaling pathway, Adipocytokine signaling pathway, Alcoholic liver disease, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway 💬1件: 285 💬
92Metformin hydrochloride
(METFORMIN HYDROCHLORIDE EXTENDED RELEASE, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE 500MG)		1件: Metformin2件: Metformin hydrochloride (METFORMIN HYDROCHLORIDE EXTENDED RELEASE, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE 500MG),
Metformin 💬 		2件: PRKAA,
PRKAA 💬 		20件: AMPK signaling pathway, Adipocytokine signaling pathway, Alcoholic liver disease, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway 💬5件: 81, 158, 265, 299, 301 💬
93Metformin hydrochloride 850 MG oral tablet
(METFORMIN HYDROCHLORIDE EXTENDED RELEASE, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE 500MG)		1件: Metformin2件: Metformin hydrochloride (METFORMIN HYDROCHLORIDE EXTENDED RELEASE, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE 500MG),
Metformin 💬 		2件: PRKAA,
PRKAA 💬 		20件: AMPK signaling pathway, Adipocytokine signaling pathway, Alcoholic liver disease, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway 💬1件: 13 💬
94Metformin treatment
(METFORMIN HYDROCHLORIDE EXTENDED RELEASE, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE 500MG)		1件: Metformin2件: Metformin hydrochloride (METFORMIN HYDROCHLORIDE EXTENDED RELEASE, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE 500MG),
Metformin 💬 		2件: PRKAA,
PRKAA 💬 		20件: AMPK signaling pathway, Adipocytokine signaling pathway, Alcoholic liver disease, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway 💬1件: 46 💬
95Metformin XR
(METFORMIN HYDROCHLORIDE EXTENDED RELEASE, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE 500MG)		1件: Metformin2件: Metformin hydrochloride (METFORMIN HYDROCHLORIDE EXTENDED RELEASE, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE 500MG),
Metformin 💬 		2件: PRKAA,
PRKAA 💬 		20件: AMPK signaling pathway, Adipocytokine signaling pathway, Alcoholic liver disease, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway 💬1件: 67 💬
96Metformin/CP-690,550
(METFORMIN HYDROCHLORIDE EXTENDED RELEASE, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE 500MG)		1件: Metformin2件: Metformin hydrochloride (METFORMIN HYDROCHLORIDE EXTENDED RELEASE, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE 500MG),
Metformin 💬 		2件: PRKAA,
PRKAA 💬 		20件: AMPK signaling pathway, Adipocytokine signaling pathway, Alcoholic liver disease, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway 💬1件: 46 💬
97Methylphenidate
(METHYLPHENIDATE HYDROCHLORIDE EXTENDED RELEASE)		1件: Methylphenidate2件: Methylphenidate hydrochloride (METHYLPHENIDATE HYDROCHLORIDE EXTENDED RELEASE),
Methylphenidate 💬 		2件: SLC6A2,
SLC6A3 💬 		8件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Neuroactive ligand signaling, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle 💬5件: 6, 13, 34, 84, 113 💬
98Methylphenidate 10MG tablets
(METHYLPHENIDATE HYDROCHLORIDE EXTENDED RELEASE)		1件: Methylphenidate2件: Methylphenidate hydrochloride (METHYLPHENIDATE HYDROCHLORIDE EXTENDED RELEASE),
Methylphenidate 💬 		2件: SLC6A2,
SLC6A3 💬 		8件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Neuroactive ligand signaling, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle 💬1件: 84 💬
99Methylphenidate hydrochloride
(METHYLPHENIDATE HYDROCHLORIDE EXTENDED RELEASE)		1件: Methylphenidate2件: Methylphenidate hydrochloride (METHYLPHENIDATE HYDROCHLORIDE EXTENDED RELEASE),
Methylphenidate 💬 		2件: SLC6A2,
SLC6A3 💬 		8件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Neuroactive ligand signaling, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle 💬2件: 6, 13 💬
100Methylphenidate modified release1件: Methylphenidate2件: Methylphenidate hydrochloride (METHYLPHENIDATE HYDROCHLORIDE EXTENDED RELEASE),
Methylphenidate 💬 		2件: SLC6A2,
SLC6A3 💬 		8件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Neuroactive ligand signaling, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle 💬1件: 13 💬
101Methylphenidate modified release 20 MG1件: Methylphenidate2件: Methylphenidate hydrochloride (METHYLPHENIDATE HYDROCHLORIDE EXTENDED RELEASE),
Methylphenidate 💬 		2件: SLC6A2,
SLC6A3 💬 		8件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Neuroactive ligand signaling, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle 💬1件: 13 💬
102Methylphenidate modified release 30 MG1件: Methylphenidate2件: Methylphenidate hydrochloride (METHYLPHENIDATE HYDROCHLORIDE EXTENDED RELEASE),
Methylphenidate 💬 		2件: SLC6A2,
SLC6A3 💬 		8件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Neuroactive ligand signaling, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle 💬1件: 13 💬
103Methylphenidate modified release 40 MG1件: Methylphenidate2件: Methylphenidate hydrochloride (METHYLPHENIDATE HYDROCHLORIDE EXTENDED RELEASE),
Methylphenidate 💬 		2件: SLC6A2,
SLC6A3 💬 		8件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Neuroactive ligand signaling, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle 💬1件: 13 💬
104Methylphenidate oral solution
(METHYLPHENIDATE HYDROCHLORIDE EXTENDED RELEASE)		1件: Methylphenidate2件: Methylphenidate hydrochloride (METHYLPHENIDATE HYDROCHLORIDE EXTENDED RELEASE),
Methylphenidate 💬 		2件: SLC6A2,
SLC6A3 💬 		8件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Neuroactive ligand signaling, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle 💬1件: 206 💬
105Methylphenidate, fluoxetin, risperidone
(METHYLPHENIDATE HYDROCHLORIDE EXTENDED RELEASE)		1件: Methylphenidate2件: Methylphenidate hydrochloride (METHYLPHENIDATE HYDROCHLORIDE EXTENDED RELEASE),
Methylphenidate 💬 		2件: SLC6A2,
SLC6A3 💬 		8件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Neuroactive ligand signaling, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle 💬2件: 179, 206 💬
106Mexiletine granules FOR prolonged-release oral suspension1件: Mexiletine2件: Mexiletine hydrochloride ,
Mexiletine 💬 		5件: SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN9A 💬 		3件: Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 💬1件: 113 💬
107Mezavant gastro-resistant, prolonged release tablets1件: Mesalazine1件: Mesalamine 💬 --1件: 97 💬
108Mezavant XL 1200 MG gastro-resistant prolonged release tablets1件: Mesalazine1件: Mesalamine 💬 --1件: 97 💬
109Mezavant XL 1200 MG gastro-resistant, prolonged release tablets1件: Mesalazine1件: Mesalamine 💬 --1件: 97 💬
110Mezavant XL 1200MG gastro-resistant, prolonged release tablets1件: Mesalazine1件: Mesalamine 💬 --1件: 97 💬
111Mezavant XL gastro-resistant, prolonged release tablets1件: Mesalazine1件: Mesalamine 💬 --1件: 97 💬
112MG01CI extended-release tablet----1件: 206 💬
113Mirapexin extended release various strengths1件: Pramipexole2件: Pramipexole dihydrochloride ,
Pramipexole 💬 		3件: DRD2,
DRD3,
DRD4 💬 		10件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
114Modified-release phosphatidylcholine----1件: 97 💬
115Nalbuphine extended-release (ER) tablets1件: Nalbuphine2件: Nalbuphine hydrochloride ,
Nalbuphine 💬 		3件: OPRD1,
OPRK1,
OPRM1 💬 		7件: Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬1件: 85 💬
116Octreotide acetate prolonged release, 30 MG1件: Octreotide4件: Octreotide ,
Octreotide acetate ,
Octreotide pamoate ,
Octreotide acetate 💬 		1件: SSTR2 💬 5件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 77 💬
117Oral treprostinil (UT-15C) sustained release tablets----1件: 86 💬
118Oxycodone naloxone prolonged release tablets1件: Oxycodone3件: Oxycodone hydrochloride ,
Oxycodone terephthalate ,
Oxycodone 💬 		3件: OPRD1,
OPRK1,
OPRM1 💬 		7件: Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬1件: 226 💬
119Oxycodone/naloxone prolonged release T2件: Naloxone,
Oxycodone		6件: Oxycodone hydrochloride ,
Naloxone hydrochloride ,
Oxycodone terephthalate ,
Oxycodone ,
Naloxone ,
Naloxone hydrochloride dihydrate 💬 		3件: OPRD1,
OPRK1,
OPRM1 💬 		7件: Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬1件: 226 💬
120Oxycodone/naloxone prolonged release tablets1件: Oxycodone3件: Oxycodone hydrochloride ,
Oxycodone terephthalate ,
Oxycodone 💬 		3件: OPRD1,
OPRK1,
OPRM1 💬 		7件: Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬1件: 6 💬
121Oxycodone/naloxone prolonged release tablets 10 MG /5 MG2件: Naloxone,
Oxycodone		6件: Oxycodone hydrochloride ,
Naloxone hydrochloride ,
Oxycodone terephthalate ,
Oxycodone ,
Naloxone ,
Naloxone hydrochloride dihydrate 💬 		3件: OPRD1,
OPRK1,
OPRM1 💬 		7件: Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬1件: 6 💬
122Oxycodone/naloxone prolonged release tablets 10/5 MG2件: Naloxone,
Oxycodone		6件: Oxycodone hydrochloride ,
Naloxone hydrochloride ,
Oxycodone terephthalate ,
Oxycodone ,
Naloxone ,
Naloxone hydrochloride dihydrate 💬 		3件: OPRD1,
OPRK1,
OPRM1 💬 		7件: Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬1件: 226 💬
123Oxycodone/naloxone prolonged release tablets 20 MG /10 MG2件: Naloxone,
Oxycodone		6件: Oxycodone hydrochloride ,
Naloxone hydrochloride ,
Oxycodone terephthalate ,
Oxycodone ,
Naloxone ,
Naloxone hydrochloride dihydrate 💬 		3件: OPRD1,
OPRK1,
OPRM1 💬 		7件: Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬1件: 6 💬
124Oxycodone/naloxone prolonged release tablets 20/10 MG2件: Naloxone,
Oxycodone		6件: Oxycodone hydrochloride ,
Naloxone hydrochloride ,
Oxycodone terephthalate ,
Oxycodone ,
Naloxone ,
Naloxone hydrochloride dihydrate 💬 		3件: OPRD1,
OPRK1,
OPRM1 💬 		7件: Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬1件: 226 💬
125Oxycodone/naloxone prolonged release tablets 5 MG /2.5 MG2件: Naloxone,
Oxycodone		6件: Oxycodone hydrochloride ,
Naloxone hydrochloride ,
Oxycodone terephthalate ,
Oxycodone ,
Naloxone ,
Naloxone hydrochloride dihydrate 💬 		3件: OPRD1,
OPRK1,
OPRM1 💬 		7件: Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬1件: 6 💬
126Oxycodone/naloxone prolonged release tablets 5/2.5 MG2件: Naloxone,
Oxycodone		6件: Oxycodone hydrochloride ,
Naloxone hydrochloride ,
Oxycodone terephthalate ,
Oxycodone ,
Naloxone ,
Naloxone hydrochloride dihydrate 💬 		3件: OPRD1,
OPRK1,
OPRM1 💬 		7件: Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬1件: 226 💬
127Pancrelipase delayed release1件: Pancrelipase2件: Pancreatin ,
Pancrelipase 💬 		--1件: 299 💬
128Pancrelipase delayed release capsule1件: Pancrelipase2件: Pancreatin ,
Pancrelipase 💬 		--2件: 298, 299 💬
129Pantoprazole
(PANTOPRAZOLE SODIUM DELAYED-RELEASE)		1件: Pantoprazole2件: Pantoprazole sodium (PANTOPRAZOLE SODIUM DELAYED-RELEASE),
Pantoprazole 💬 		2件: ATP4A,
ATP4B 💬 		3件: Collecting duct acid secretion, Gastric acid secretion, Oxidative phosphorylation 💬2件: 13, 65 💬
130Pasireotide long acting release formulation1件: Pasireotide3件: Pasireotide ,
Pasireotide diaspartate ,
Pasireotide pamoate 💬 		4件: SSTR1,
SSTR2,
SSTR3,
SSTR5 💬 		5件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 77 💬
131Pentasa compact 2G, granulate with prolonged release1件: Mesalazine1件: Mesalamine 💬 --1件: 97 💬
132Pentasa compact 4G, granulate with prolonged release1件: Mesalazine1件: Mesalamine 💬 --1件: 97 💬
133Pentasa prolonged release granules 2G1件: Mesalazine1件: Mesalamine 💬 --1件: 97 💬
134Pentasa sachet 1 G prolonged release granules1件: Mesalazine1件: Mesalamine 💬 --1件: 96 💬
135Pioglitazone or metformin
(METFORMIN HYDROCHLORIDE EXTENDED RELEASE, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE 500MG)		1件: Pioglitazone2件: Pioglitazone hydrochloride ,
Pioglitazone 💬 		1件: NR1C3 💬 12件: AMPK signaling pathway, Efferocytosis, Huntington disease, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer 💬1件: 265 💬
136Pirfenidone modified-release tablets1件: Pirfenidone1件: Pirfenidone 💬 6件: CCL2,
IL10,
IL1A,
IL1B,
IL6,
TNF 💬 		83件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, Autoimmune thyroid disease, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Chemokine signaling pathway, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Dilated cardiomyopathy, Efferocytosis, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Inflammatory mediator regulation of TRP channels, Influenza A, Insulin resistance, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Staphylococcus aureus infection, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 85 💬
137Plenadren 20 MG modified-release tablets1件: Hydrocortisone1件: Hydrocortisone 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 78 💬
138Plenadren 5 MG modified-release tablets1件: Hydrocortisone1件: Hydrocortisone 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 78 💬
139Posaconazole delayed release oral tablet1件: Posaconazole1件: Posaconazole 💬 --1件: 96 💬
140Potassium chloride
(POTASSIUM CHLORIDE EXTENDED RELEASE, POTASSIUM CHLORIDE EXTENDED-RELEASE)		2件: Potassium,
Potassium chloride		2件: Potassium chloride (POTASSIUM CHLORIDE EXTENDED RELEASE, POTASSIUM CHLORIDE EXTENDED-RELEASE),
Potassium 💬 		--1件: 97 💬
141Pramipexol extended release1件: Pramipexole2件: Pramipexole dihydrochloride ,
Pramipexole 💬 		3件: DRD2,
DRD3,
DRD4 💬 		10件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
142Pramipexol immediate release1件: Pramipexole2件: Pramipexole dihydrochloride ,
Pramipexole 💬 		3件: DRD2,
DRD3,
DRD4 💬 		10件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
143Pramipexole dihydrochloride extended-release tablets1件: Pramipexole2件: Pramipexole dihydrochloride ,
Pramipexole 💬 		3件: DRD2,
DRD3,
DRD4 💬 		10件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
144Pramipexole dihydrochloride monohydrate extended release1件: Pramipexole2件: Pramipexole dihydrochloride ,
Pramipexole 💬 		3件: DRD2,
DRD3,
DRD4 💬 		10件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
145Pramipexole extended release1件: Pramipexole2件: Pramipexole dihydrochloride ,
Pramipexole 💬 		3件: DRD2,
DRD3,
DRD4 💬 		10件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
146Pramipexole extended release tablet1件: Pramipexole2件: Pramipexole dihydrochloride ,
Pramipexole 💬 		3件: DRD2,
DRD3,
DRD4 💬 		10件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
147Pramipexole immediate release1件: Pramipexole2件: Pramipexole dihydrochloride ,
Pramipexole 💬 		3件: DRD2,
DRD3,
DRD4 💬 		10件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
148Pramipexole immediate release tablet1件: Pramipexole2件: Pramipexole dihydrochloride ,
Pramipexole 💬 		3件: DRD2,
DRD3,
DRD4 💬 		10件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
149Pregabalin
(PREGABALIN EXTENDED RELEASE)		1件: Pregabalin1件: Pregabalin (PREGABALIN EXTENDED RELEASE) 💬 4件: CACNA2D1,
CACNA2D2,
CACNA2D3,
CACNA2D4 💬 		7件: Adrenergic signaling in cardiomyocytes, Arrhythmogenic right ventricular cardiomyopathy, Cardiac muscle contraction, Dilated cardiomyopathy, Hypertrophic cardiomyopathy, MAPK signaling pathway, Oxytocin signaling pathway 💬5件: 13, 36, 46, 70, 298 💬
150Pregabalin 75MG
(PREGABALIN EXTENDED RELEASE)		1件: Pregabalin1件: Pregabalin (PREGABALIN EXTENDED RELEASE) 💬 4件: CACNA2D1,
CACNA2D2,
CACNA2D3,
CACNA2D4 💬 		7件: Adrenergic signaling in cardiomyocytes, Arrhythmogenic right ventricular cardiomyopathy, Cardiac muscle contraction, Dilated cardiomyopathy, Hypertrophic cardiomyopathy, MAPK signaling pathway, Oxytocin signaling pathway 💬1件: 70 💬
151Prolonged release tablet----1件: 6 💬
152Prolonged-release fampridine----1件: 13 💬
153Ranolazine PR (prolonged-release) 500 MG 1 tablet BIS IN DIE and 750 MG 1 tablet BIS IN DIE1件: Ranolazine2件: Ranolazine ,
Ranolazine hydrochloride 💬 		--1件: 58 💬
154Requip prolonged release1件: Ropinirole2件: Ropinirole hydrochloride ,
Ropinirole 💬 		3件: DRD2,
DRD3,
DRD4 💬 		10件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
155Requip XL prolonged-release1件: Ropinirole2件: Ropinirole hydrochloride ,
Ropinirole 💬 		3件: DRD2,
DRD3,
DRD4 💬 		10件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
156Retarded release phosphatidylcholine----1件: 97 💬
157Rifaximin delayed release 400 MG film coated tablet1件: Rifaximin1件: Rifaximin 💬 --1件: 96 💬
158Rifaximin delayed release tablets1件: Rifaximin1件: Rifaximin 💬 --1件: 96 💬
159Ropinirole controlled-release (requip CR) FOR RLS1件: Ropinirole2件: Ropinirole hydrochloride ,
Ropinirole 💬 		3件: DRD2,
DRD3,
DRD4 💬 		10件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
160Ropinirole hydrochloride prolonged release1件: Ropinirole2件: Ropinirole hydrochloride ,
Ropinirole 💬 		3件: DRD2,
DRD3,
DRD4 💬 		10件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
161Ropinirole immediate release1件: Ropinirole2件: Ropinirole hydrochloride ,
Ropinirole 💬 		3件: DRD2,
DRD3,
DRD4 💬 		10件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
162Ropinirole prolonged release1件: Ropinirole2件: Ropinirole hydrochloride ,
Ropinirole 💬 		3件: DRD2,
DRD3,
DRD4 💬 		10件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
163Rosiglitazone extended release tablets1件: Rosiglitazone2件: Rosiglitazone maleate ,
Rosiglitazone 💬 		1件: NR1C3 💬 12件: AMPK signaling pathway, Efferocytosis, Huntington disease, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer 💬1件: 46 💬
164Rotigotine, extended-release microspheres1件: Rotigotine1件: Rotigotine 💬 1件: DRD2 💬 10件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
165Salofalk 3G gastro-resistant prolonged-release granules1件: Mesalazine1件: Mesalamine 💬 --1件: 97 💬
166Sinemet CR 25MG-100MG extended-release tablet2件: Carbidopa,
Levodopa		2件: Levodopa ,
Carbidopa 💬 		6件: DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬 		17件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6 💬
167SPD476 IS A polymeric matrix formulation that displays both delayed- and extended-release OF mesalazine1件: Mesalazine1件: Mesalamine 💬 --1件: 97 💬
168Sustained-release carbidopa/levodopa----1件: 6 💬
169Sustained-release oral dalfampridine----1件: 13 💬
170Tacrolimus prolonged-release hard capsules1件: Tacrolimus2件: Tacrolimus ,
Tacrolimus 💬 		5件: PPP3C,
PPP3C,
PPP3C,
PPP3R,
PPP3R 💬 		33件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬1件: 299 💬
171Targinact 10 MG/5 MG prolonged-release tablets----2件: 6, 226 💬
172Targinact 20 MG/10 MG prolonged-release tablets----1件: 6 💬
173Targinact 20MG/10 MG prolonged-release tablets----1件: 226 💬
174Targinact 5 MG/2.5 MG prolonged-release tablets----1件: 6 💬
175Targinact 5MG/2.5 MG prolonged-release tablets----1件: 226 💬
176Tarpeyo 4 MG delayed release oral capsule----1件: 66 💬
177Tofacitinib (xeljanz®) 11MG prolonged release tablet1件: Tofacitinib2件: Tofacitinib citrate ,
Tofacitinib 💬 		4件: JAK1,
JAK2,
JAK3,
TYK2 💬 		39件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, Efferocytosis, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Hormone signaling, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬1件: 46 💬
178Tolterodine
(TOLTERODINE TARTRATE EXTENDED RELEASE)		1件: Tolterodine2件: Tolterodine ,
Tolterodine tartrate (TOLTERODINE TARTRATE EXTENDED RELEASE) 💬 		1件: CHRM3 💬 12件: Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction 💬1件: 17 💬
179Upadacitinib extended release oral tablet1件: Upadacitinib3件: Upadacitinib ,
Upadacitinib tartrate ,
Upadacitinib hydrate 💬 		1件: JAK1 💬 27件: Coronavirus disease - COVID-19, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬1件: 97 💬
180Venlafaxine
(VENLAFAXINE HYDROCHLORIDE, EXTENDED RELEASE)		1件: Venlafaxine3件: Venlafaxine hydrochloride (VENLAFAXINE HYDROCHLORIDE, EXTENDED RELEASE),
Venlafaxine ,
Venlafaxine besylate monohydrate 💬 		2件: SLC6A2,
SLC6A4 💬 		3件: Neuroactive ligand signaling, Serotonergic synapse, Synaptic vesicle cycle 💬3件: 6, 13, 97 💬
181Venlafaxine hydrochloride
(VENLAFAXINE HYDROCHLORIDE, EXTENDED RELEASE)		1件: Venlafaxine3件: Venlafaxine hydrochloride (VENLAFAXINE HYDROCHLORIDE, EXTENDED RELEASE),
Venlafaxine ,
Venlafaxine besylate monohydrate 💬 		2件: SLC6A2,
SLC6A4 💬 		3件: Neuroactive ligand signaling, Serotonergic synapse, Synaptic vesicle cycle 💬2件: 13, 46 💬
182WD-1603 carbidopa and levodopa extended-release tablets----1件: 6 💬
183WD-1603 carbidopa-levodopa extended-release tablets----1件: 6 💬
184WD-1603 carbidopa/levodopa extended-release tablets----1件: 6 💬
185Xeljanz® 11MG prolonged release tablet1件: Tofacitinib2件: Tofacitinib citrate ,
Tofacitinib 💬 		4件: JAK1,
JAK2,
JAK3,
TYK2 💬 		39件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, Efferocytosis, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Hormone signaling, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬1件: 46 💬